Eye-watering!
It has five funds returning more than 100% from April thru November … six, if you count the one it sub-advises ... see here.
Five of its funds have returned more than 80% YTD!

This link seems a little dated, but it seems to answer some of your questions. I would verify any changes for 2020.
https://finance.zacks.com/can-shortterm-capital-loss-tax-writeoff-against-ordinary-gains-3687.html

Notes:
- Ark ETFs are actively managed ETFs.
-The concept of "cash-like equities" is mentioned by Ms Woods.
What are your cash like equity mutual funds?
-Tesla's future aims at Autonomous Taxi Services.
-Bitcoin is the flight to safety currency in Cryptocurrency space. Large gains will be captured by the IRS, not the individual investor.
-Social Media continues to be an important part of modern day financial services.
-Capitalizing on how the world is changing:
- Artificial Intelligence, Robotics, Energy Storage, DNA Sequencing & The Blockchain.
- Quantum Computing

Problem Solving Portfolios:

“Disruptive innovation is often not priced correctly by traditional investment strategies because people may not understand how big the ultimate opportunities are going to be. They aren’t sizing the opportunity and they aren’t analyzing the disruption.”

https://bloomberg.com/news/articles/2020-12-18/cathie-wood-sees-control-fight-ending-lifting-cloud-over-ark?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link&sref=DWzi38c2

Waiting to "buy the dips" (the strategy to wait for a 10% peak-to-trough loss before buying, then holding for at least 12 months or until the drawdown threshold is exceeded before returning to cash) doesn't work verses Just "Buy and Hold":

Linked Article:
reasons-why-you-shouldnt-wait-for-the-stock-market-to-crash

I was wondering if the below info is correct as per the writer , especially the $3K to offset other ordinary income ? I was thinking write off $2k & carry forward the remainder $4K
Another thing you should know is that you don't need to use up your entire capital loss for the tax year in which you take it. Say you take a $6,000 loss this year, but you only have $2,000 in capital gains to negate. From there, you're left with $4,000, of which $3,000 can be used to offset ordinary income. But you don't lose the remaining $1,000 tax benefit. Instead, you can carry it with you into 2021 and use it then.
Merry Christmas to All, Derf

@msf. agreed- Several great ideas ! ( thanks ) and I think it has gotten a bit confusing because....
1. I asked to consider a "global blend manager" in the hopes that might put the decision making between Value & growth in the hands of the manager. Perhaps that is not the smartest way to gain the exposure that I think I need. As I stated in the opening post - it has been a long wait for the value proposition to kick in. I welcome your comments on the issue of Value vs. Growth at this time
Here are my priorities
2. I am willing to give up on the upside for protection on the downside - so I have been looking at the Sharpe and Martin Ratio, and Max DD in the MFO screener. Is there better process for evaluating the risk ?
3. EM was only referred to because I stated that I was moving on to researching small/mid and EM next/separately - I am not screening it as an alt to TBGVX.
TBGVX is 68% Western Europe 13% U.S (that slug of US probably helped the performance vs. a strict Foreign only fund - ARTKX has outperformed in 1/3/5 years, but as you point out has had steeper MAXDD in 2011 and 2018.
I am already holding MINIX, TBGVX (in a 401k that I did not sell), DFALX that I can't sell due to cap gains in it.
does that add clarity ? Your advice is welcome.

Since 1988, investing at all time highs of the S & P 500, has been a better strategy:

Article:
investing-in-stocks-at-all-time-highs/
Article on Investing During Market Highs:
what-if-you-only-invested-at-market-peaks

PRCNX lands in Morningstar's Foreign Large Blend category although its investment style was classified as Foreign Large Value in 2019 and 2020. The fund's trailing 3 Yr. and 5 Yr. returns were average while its risk was below average (according to M*).
The lead manager, Federico Santilli, has also steered RPICX (PRCNX clone) since 07-27-10.
Since inception, RPICX annual returns have been top-quartile in six out of nine calendar years.
The fund's trailing 10 Yr. return was top decile while its risk was low (according to M*).
Here's a snippet of William Rocco's (M*) take on PRCNX published on 11-25-20.
Santilli pursues compellingly priced companies with superior
competitive positions in attractive industries, strong
fundamentals, solid balance sheets, and proven
leadership. While doing so, he invests across the
market-cap and style spectrums, readily allows his
stock selection to lead to atypical country and sector
exposures, and invests in roughly 60-70 stocks while
keeping the largest positions moderate in size. This
approach is sound and distinctive and has an attractive
mix of bolder and tamer traits that provide this fund
with a fighting chance of outperformance without
taking on excessive risk.

https://www.sec.gov/Archives/edgar/data/1697196/000158064220004585/acpmi497.htm
497 1 acpmi497.htm 497
AlphaCentric Prime Meridian Income Fund
(the “Fund”)
December 22, 2020
The information in this Supplement amends certain information contained in the Fund’s current Prospectus and Statement of Additional information (“SAI”), each dated April 24, 2020.
______________________________________________________________________________
The Fund’s Board of Trustees approved increases in the minimum purchase requirements for regular accounts from $2,500 to $10,000 and for retirement plan accounts from $1,000 to $10,000.
All references to the minimum investment amounts contained in the Fund’s Prospectus and SAI are hereby revised accordingly.
* * *
You should read this Supplement in conjunction with the Fund’s Prospectus and SAI, which provide information that you should know about the Fund before investing. These documents are available upon request and without charge by calling the Fund toll-free at 1-888-910-0412, or by writing to the Fund at c/o U.S. Bancorp Fund Services, LLC, 615 East Michigan Street, Milwaukee, Wisconsin 53202.
Please retain this Supplement for future reference.

M* shows a manager change at the New Year, 2018-2019. Not long ago!
"The fund is notable for what it doesn't own. The focus here is on traditional real estate, so the fund typically doesn't hold data center and infrastructure REITs, such as cell tower companies. The fund has historically tended to be light on healthcare REITs, owing to the long-term length of leases and specialized uses that potentially limit resale value. However, Jones has added to the portfolio's healthcare holdings, so that as of March 31, 2020, it was only slightly underweight in that area relative to the Wilshire US Real Estate Securities Index." I have owned TRREX, but not for long. I note the DISTRIBUTIONS have indeed been juicy.

Not sure I should trust since it refers to 'Dartmouth University', but good for a smile.
https://phys.org/news/2020-12-santa-reindeer-outdo-senators-stocks.html

Fell for both CGMFX and FAIRX. Did okay on CGMFX; got out of FAIRX too late to have realized net gains beyond what a decent bond fund would have given me over the same period.
Kick myself a bit on FAIRX because I knew I wasn't comfortable with the way Bruce was getting waaaay too overexposed, as well as some of his bizarre personnel decisions. He was spending a bit too much time drinking his own bathwater, and I ultimately got too nervous and XFER'd out.
Now, as a rule, I never let such "moonshot" active funds be more than 7.5% of my total portfolio.

Found more information on Ben Griffins at M* (including mis-spelling on his name)

Ben Griffins
03/01/2020 —
Ben Griffins is a vice president of T. Rowe Price Group, Inc. and T. Rowe Price International Ltd and an investment analyst in the Equity Research Team of T. Rowe Price International Ltd, covering European small-cap stocks. Ben has been with the firm since 2006. Prior to joining T. Rowe Price, he was an investment manager with Baillie Gifford. Ben earned a diploma in investment analysis from Stirling University and an M.Eng. in engineering science from Oxford University. He also has earned his Chartered Financial Analyst designation.
Certification Chartered Financial Analyst
Education
M.S. University of Oxford,
Other Assets Managed

financials.morningstar.com/fund/management.html?t=PRIDX&region=usa&culture=en-US

Does anyone has more background information on Ben Griffins? He is listed as co-manager who joined Justin Thomson since March 2020. I would expect this transition plan has been in place for some time - 9 months is a bit short. Perhaps Ben Griffins has experience co-managing other international funds.

https://www.sec.gov/Archives/edgar/data/1440930/000174177320003676/c497.htm
497 1 c497.htm
T. Rowe Price Global Real Estate Fund
Supplement to Prospectus Dated May 1, 2020
In section 1, the portfolio manager table under “Management” is supplemented as follows:
Effective April 1, 2021, Jai Kapadia will become portfolio manager and Chair of the fund’s Investment Advisory Committee and Nina Jones will transition from her role as portfolio manager and Chair of the fund’s Investment Advisory Committee. Mr. Kapadia joined T. Rowe Price in 2011.
In section 2, the disclosure under “Portfolio Management” is supplemented as follows:
Effective April 1, 2021, Jai Kapadia will become portfolio manager and Chair of the fund’s Investment Advisory Committee and Nina Jones will transition from her role as portfolio manager and Chair of the fund’s Investment Advisory Committee. Mr. Kapadia joined T. Rowe Price in 2011 and his investment experience dates from 2004. During the past five years, Mr. Kapadia served as a member of the fund’s Investment Advisory Committee responsible for selecting the fund’s investments in the Asia-Pacific region (beginning 2019) and previously, as an analyst and associate director of research in the Equity Research Group of T. Rowe Price in Hong Kong, covering Asian conglomerates, real estate and Indian pharmaceuticals.
The date of this supplement is December 21, 2020.
F173-041 12/21/20

https://www.sec.gov/Archives/edgar/data/313212/000174177320003678/c497.htm
497 1 c497.htm
T. Rowe Price International Discovery Fund
Supplement to Prospectus Dated December 15, 2020
In section 1, the portfolio manager table under “Management” is supplemented as follows:
Effective January 1, 2021, Mr. Thomson will step down as a portfolio manager and Cochair of the fund’s Investment Advisory Committee. Mr. Griffiths will remain as portfolio manager and Chair of the fund’s Investment Advisory Committee.
In section 2, the disclosure under “Portfolio Management” is supplemented as follows:
Effective January 1, 2021, Mr. Thomson will step down as a portfolio manager and Cochair of the fund’s Investment Advisory Committee. Mr. Griffiths will remain as portfolio manager and Chair of the fund’s Investment Advisory Committee.
The date of this supplement is December 21, 2020.
F38-041 12/21/20

John Hussman's market forecasts were consistently very wrong over the past decade.
Investors should just ignore his prognostications. Link

I haven't heard much about Ken Heebner in years.
He was a real "cowboy" investment manager back in the day.
The trailing returns for the CGM Focus Fund occupy the bottom percentile (100) in the Large Blend category for the 1,3,5,10, and 15 year periods ending 12-18-2020.
The fund's standard deviation is also considerably higher than that of its category peers.

By March of 2009, Miller's flagship had drawn down about 80 percent. He only drew down half that 11 years later. How does he get the new capital to take advantage?

That is a sure way to fund his yacht while his investors stay poor. Glad I never invest with Bill Miller. He still paddles his investment view on WealthTrack.